U.S. Compensates Those Injured by COVID-19 Vaccines

Originally published April 19, 2023 11:00 am PDT

This is the first time the United States has paid those adversely affected by the COVID-19 vaccine.

QUICK FACTS:
  • Three people were compensated under the Countermeasures Injury Compensation Program (CICP) for injuries caused by the COVID-19 vaccine.
  • The CICP is operated through the Department of Health and Human Services (HHS).
  • The identities of those receiving compensation, as well as which vaccine they received, are not publically known.
  • One individual who experienced severe allergic shock received $2,019, while another suffered heart inflammation and received $1,582, and the third individual, who experienced myocarditis, was given $1,032.
  • “These amounts are so low that you can credibly assume that this was just only for unreimbursed medical expenses, and that’s it,” said the author of The Vaccine Court, Wayne Rhode.
  • “It’s unconscionable what they’re doing, but that’s this program,” Rhode told to The Epoch Times.
  • Previously, people have been compensated for injuries caused by the H1N1 vaccine, some receiving over $100,000 and one individual even receiving $2.2 million.
COUNTERMEASURES INJURY COMPENSATION PROGRAM (CICP):
  • In order to receive federal government compensation from the CICP, an individual must prove they have a “causal connection” between the vaccine and an injury using “compelling, reliable, valid, medical, and scientific evidence.”
  • The individual must also file the injury within one year of its occurrence.
  • Out of the thousands of injuries that have been filed, CICP has only accepted 23.
  • Every other vaccine injury claim beyond the COVID-19 vaccine is reviewed through the National Vaccine Injury Compensation Program, where individuals may be eligible to receive greater payments.
  • The primary difference between the two programs is dependent upon how the funds are formulated, as the National Vaccine Injury Compensation Program derives its funding from taxes on each vaccine, whereas CICP funds stem from Congressional appropriations.
BACKGROUND:
  • The Biden administration launched a $5 billion program to develop new COVID-19 vaccines.
  • Project Next Gen will focus on “creating long-lasting monoclonal antibodies,” “accelerating development of vaccines that produce mucosal immunity,” and “speeding efforts to develop pan-coronavirus vaccines to guard against new SARS-CoV-2 variants.”

LATEST VIDEO